PPV: Pneumococcal Polysaccharide Vaccine in Older Adults
Completed · Phase 4
Conditions studied: Aging
In brief
The purpose of this study is to measure how long the improvement in the immune system lasts in older people after they have been vaccinated, and to examine the immune response in older people who get vaccinated a second time.
Key facts
- Study ID
- NCT00239694
- Run by
- National Institute on Aging (NIA)
- People needed
- 100
- Starts
- 2001-04-01
- Expected to finish
- 2012-08-01
- Last updated by the study team
- 2015-08-04
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Enrolled in the BLSA with at least 2 stored blood samples post vaccination
- 65 years old or older
- Previously vaccinated with Pneumovax at least 5 years ago or never vaccinated
- Willing to receive vaccination with pneumococcal and meningococcal injection
- Able to provide informed consent
- Has never received a meningococcal vaccine
You may not qualify if…
- Hypersensitivity to the pneumococcal or meningococcal vaccine
- Ever received the Meningococcal vaccine
- History of non-skin cancer
- History of myeloproliferative disorder
- History of HIV
- Received a Bone Marrow Transplant
- Taking prednisone (more than 5 mg/day) or other immunosuppressive medication
- Evidence of severe liver or renal disease (serum creatine >2.0 mg/dL or Total Bilirubin >2.0
Where it is running
- National Institute on Aging — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.